SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-13-013518
Filing Date
2013-10-28
Accepted
2013-10-28 17:18:02
Documents
5
Period of Report
2013-10-25
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K furx20131028_8k.htm 8-K 25795
2 EXHIBIT 10.36 ex10-36.htm EX-10 132547
3 EXHIBIT 10.37 ex10-37.htm EX-10 46742
4 EXHIBIT 99.1 ex99-1.htm EX-99 10155
5 ex99-1img001.jpg GRAPHIC 5217
  Complete submission text file 0001437749-13-013518.txt   223934
Mailing Address 3900 PARAMOUNT PARKWAY SUITE 150 MORRISVILLE NC 27560
Business Address 3900 PARAMOUNT PARKWAY SUITE 150 MORRISVILLE NC 27560 919-456-7800
Furiex Pharmaceuticals, Inc. (Filer) CIK: 0001484478 (see all company filings)

IRS No.: 271197863 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34641 | Film No.: 131173921
SIC: 2834 Pharmaceutical Preparations